Genetic Technologies Balance Sheet Health
Financial Health criteria checks 4/6
Genetic Technologies has a total shareholder equity of A$1.8M and total debt of A$643.5K, which brings its debt-to-equity ratio to 35.2%. Its total assets and total liabilities are A$6.2M and A$4.4M respectively.
Key information
35.2%
Debt to equity ratio
AU$643.55k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$1.04m |
| Equity | AU$1.83m |
| Total liabilities | AU$4.36m |
| Total assets | AU$6.19m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GNTL.F's short term assets (A$3.7M) do not cover its short term liabilities (A$4.2M).
Long Term Liabilities: GNTL.F's short term assets (A$3.7M) exceed its long term liabilities (A$160.6K).
Debt to Equity History and Analysis
Debt Level: GNTL.F has more cash than its total debt.
Reducing Debt: GNTL.F's debt to equity ratio has increased from 0% to 35.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GNTL.F has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: GNTL.F is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.